利润表
GALECTIN THERAPEUTICS INC
GALT
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
毛利润
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
营业费用
|
20.09 | 42.43 | 38.07 | 38.35 | 30.18 | 23.44 | 13.44 | 13.60 | 16.25 | 21.48 | 20.08 | 15.43 | 12.10 | 9.90 | 10.41 |
|
研发费用
|
14.29 | 36.57 | 32.13 | 31.74 | 23.82 | 17.98 | 7.47 | 6.47 | 11.72 | 15.33 | 13.11 | 8.43 | 5.69 | 4.53 | 3.55 |
|
销售、一般及行政费用
|
5.80 | 5.86 | 5.94 | 6.62 | 6.36 | 5.47 | 5.97 | 7.13 | 4.53 | 6.16 | 6.97 | 7.01 | 6.42 | 5.37 | 6.86 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-20.09 | -42.43 | -38.07 | -38.35 | -30.18 | -23.44 | -13.44 | -13.60 | -16.25 | -21.48 | -20.08 | -15.43 | -12.10 | -9.90 | -10.41 |
|
营业外收入
|
-10.75 | -4.61 | -2.99 | -0.42 | -0.35 | -0.02 | 0.14 | -0.30 | 0.01 | 0.05 | 0.05 | -0.36 | 0.02 | 0.22 | -0.51 |
|
利息收入
|
0.13 | 0.34 | 0.23 | 0.05 | 0.00 | 0.07 | 0.23 | 0.04 | 0.02 | 0.05 | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 |
|
利息支出
|
0.22 | 0.21 | 2.79 | 1.03 | 0.49 | 0.09 | 0.09 | 0.34 | 0.01 | - | - | - | - | - | - |
|
其他营业外收入/支出
|
- | - | - | - | - | - | - | - | - | - | - | -0.40 | - | - | - |
|
税前利润
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
所得税费用
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-30.84 | -47.05 | -41.07 | -38.78 | -30.53 | -23.47 | -13.29 | 13.90 | -16.24 | -21.44 | -20.03 | -15.79 | -12.09 | -9.68 | -10.92 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-20.09 | -42.43 | -38.07 | -38.35 | -30.18 | -23.44 | -13.44 | -13.60 | -16.25 | -21.47 | -20.07 | -15.42 | -12.09 | -9.89 | -10.40 |
|
基本每股收益
|
-0.48 | -0.76 | -0.74 | -0.65 | -0.52 | - | - | - | - | - | - | - | - | - | - |
|
稀释每股收益
|
-0.48 | -0.76 | -0.74 | -0.65 | -0.52 | - | - | - | - | - | - | - | - | - | - |
|
加权平均股数
|
63.90 | 62.31 | 60.16 | 59.39 | 58.53 | - | - | - | - | - | - | - | - | - | - |
|
稀释加权平均股数
|
63.90 | 62.31 | 60.16 | 59.39 | 58.53 | - | - | - | - | - | - | - | - | - | - |
|
综合收益
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |